FineHeart

Medical Devices & EquipmentSeries CPessac, Francefineheart.fr

Latest round

Series C

Last raised

Dec 2025

Total raised

$66M

Investors

13

About FineHeart

FineHeart, founded in 2010 in Pessac, France, specializes in medical devices aimed at improving heart failure treatments. The founders, Arnaud Mascarell and Philippe Ritter, have a history of innovation in the healthcare sector.A. specializes in developing innovative medical technology solutions for cardiology, with a primary focus on its flagship product, the FlowMaker®. This fully implantable cardiac assist device is designed to improve the treatment of patients suffering from advanced heart failure, a condition that currently has limited effective treatment options. The FlowMaker® aims to provide robust cardiac support, enhancing patients' quality of life and allowing for better management of their heart conditions. FineHeart's technology targets healthcare providers and institutions within the cardiology sector, particularly in Europe, including France, where it has received the necessary regulatory approvals to begin clinical trials.FineHeart's revenue model revolves around the commercialization of its cardiac assist device, the FlowMaker®, primarily through partnerships with healthcare institutions and medical providers. The company engages in direct sales to hospitals and clinics, which serve as the primary end-users of its technology. The company is also planning to expand its product offerings and enhance its market presence within Europe and potentially other regions following regulatory approvals. These initiatives will support the company's aim to better serve patients with heart failure and solidify its position in the medical technology space.

Who invested in FineHeart

13 investors across 3 rounds

See all investors in FineHeart

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Dec 11, 2025

    Amount

    $41M

    Investors

    Locked

  2. Series B

    Jun 1, 2021

    Amount

    $18M

    Investors

    Locked

  3. Series A

    May 17, 2016

    Amount

    $7.2M

    Investors

    Locked

Questions about FineHeart

Who invested in FineHeart?

FineHeart has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has FineHeart raised?

FineHeart has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did FineHeart last raise money?

FineHeart's most recent round on record is a Series C, in Dec 2025.

What does FineHeart do?

FineHeart, founded in 2010 in Pessac, France, specializes in medical devices aimed at improving heart failure treatments.

Where is FineHeart headquartered?

FineHeart is headquartered in Pessac, France.

Which VCs invest in companies like FineHeart?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at FineHeart's stage. Their profiles are linked below.

Raising like FineHeart? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.